HS90B_MOUSE - dbPTM
HS90B_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HS90B_MOUSE
UniProt AC P11499
Protein Name Heat shock protein HSP 90-beta
Gene Name Hsp90ab1
Organism Mus musculus (Mouse).
Sequence Length 724
Subcellular Localization Cytoplasm . Melanosome . Nucleus . Secreted . Cell membrane . Translocates with BIRC2 from the nucleus to the cytoplasm during differentiation. Secreted when associated with TGFB1 processed form (LAP).
Protein Description Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function. Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself. Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle. Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels. In the first place, they alter the steady-state levels of certain transcription factors in response to various physiological cues. Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment. Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression. Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation. Promotes cell differentiation by chaperoning BIRC2 and thereby protecting from auto-ubiquitination and degradation by the proteasomal machinery. Main chaperone that is involved in the phosphorylation/activation of the STAT1 by chaperoning both JAK2 and PRKCE under heat shock and in turn, activates its own transcription..
Protein Sequence MPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLEKEREKEISDDEAEEEKGEKEEEDKEDEEKPKIEDVGSDEEDDSGKDKKKKTKKIKEKYIDQEELNKTKPIWTRNPDDITQEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFIPRRAPFDLFENKKKKNNIKLYVRRVFIMDSCDELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNIVKKCLELFSELAEDKENYKKFYEAFSKNLKLGIHEDSTNRRRLSELLRYHTSQSGDEMTSLSEYVSRMKETQKSIYYITGESKEQVANSAFVERVRKRGFEVVYMTEPIDEYCVQQLKEFDGKSLVSVTKEGLELPEDEEEKKKMEESKAKFENLCKLMKEILDKKVEKVTISNRLVSSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMMAKKHLEINPDHPIVETLRQKAEADKNDKAVKDLVVLLFETALLSSGFSLEDPQTHSNRIYRMIKLGLGIDEDEVTAEEPSAAVPDEIPPLEGDEDASRMEEVD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
33PhosphorylationSLIINTFYSNKEIFL
HHHHHHHCCCHHHHH
14.86-
45PhosphorylationIFLRELISNASDALD
HHHHHHHHCHHHHHH
38.6818779572
48PhosphorylationRELISNASDALDKIR
HHHHHCHHHHHHHHC
27.8918779572
53AcetylationNASDALDKIRYESLT
CHHHHHHHHCHHHCC
29.9023806337
53SuccinylationNASDALDKIRYESLT
CHHHHHHHHCHHHCC
29.9023806337
53UbiquitinationNASDALDKIRYESLT
CHHHHHHHHCHHHCC
29.90-
56PhosphorylationDALDKIRYESLTDPS
HHHHHHCHHHCCCHH
17.2221183079
58PhosphorylationLDKIRYESLTDPSKL
HHHHCHHHCCCHHHC
27.8624899341
60PhosphorylationKIRYESLTDPSKLDS
HHCHHHCCCHHHCCC
55.9621183079
63PhosphorylationYESLTDPSKLDSGKE
HHHCCCHHHCCCCCE
48.9721183079
64UbiquitinationESLTDPSKLDSGKEL
HHCCCHHHCCCCCEE
62.8022790023
67PhosphorylationTDPSKLDSGKELKID
CCHHHCCCCCEEEEE
63.3029514104
69MalonylationPSKLDSGKELKIDII
HHHCCCCCEEEEEEC
64.9226320211
69UbiquitinationPSKLDSGKELKIDII
HHHCCCCCEEEEEEC
64.92-
72AcetylationLDSGKELKIDIIPNP
CCCCCEEEEEECCCH
39.1523806337
72SuccinylationLDSGKELKIDIIPNP
CCCCCEEEEEECCCH
39.1523806337
72UbiquitinationLDSGKELKIDIIPNP
CCCCCEEEEEECCCH
39.15-
94PhosphorylationVDTGIGMTKADLINN
EECCCCCCHHHHHHH
20.1920139300
95UbiquitinationDTGIGMTKADLINNL
ECCCCCCHHHHHHHH
30.8922790023
104PhosphorylationDLINNLGTIAKSGTK
HHHHHHHHHHHHHHH
22.4129514104
107UbiquitinationNNLGTIAKSGTKAFM
HHHHHHHHHHHHHHH
45.6422790023
111UbiquitinationTIAKSGTKAFMEALQ
HHHHHHHHHHHHHHH
43.05-
155PhosphorylationKHNDDEQYAWESSAG
CCCCCCCEEEECCCC
16.1925168779
159PhosphorylationDEQYAWESSAGGSFT
CCCEEEECCCCCEEE
18.1326525534
160PhosphorylationEQYAWESSAGGSFTV
CCEEEECCCCCEEEE
21.2926525534
164PhosphorylationWESSAGGSFTVRADH
EECCCCCEEEEEECC
19.4725168779
166PhosphorylationSSAGGSFTVRADHGE
CCCCCEEEEEECCCC
15.6925168779
180UbiquitinationEPIGRGTKVILHLKE
CCCCCCCEEEEEECC
30.0622790023
186UbiquitinationTKVILHLKEDQTEYL
CEEEEEECCCHHHHH
48.8022790023
190PhosphorylationLHLKEDQTEYLEERR
EEECCCHHHHHHHHH
38.6328066266
192PhosphorylationLKEDQTEYLEERRVK
ECCCHHHHHHHHHHH
23.8517242355
204AcetylationRVKEVVKKHSQFIGY
HHHHHHHHHHHHCCC
36.5623806337
204SuccinylationRVKEVVKKHSQFIGY
HHHHHHHHHHHHCCC
36.5623806337
204UbiquitinationRVKEVVKKHSQFIGY
HHHHHHHHHHHHCCC
36.56-
211PhosphorylationKHSQFIGYPITLYLE
HHHHHCCCCEEEEEH
6.1429899451
214PhosphorylationQFIGYPITLYLEKER
HHCCCCEEEEEHHHH
12.5926745281
216PhosphorylationIGYPITLYLEKEREK
CCCCEEEEEHHHHHH
12.2626745281
219AcetylationPITLYLEKEREKEIS
CEEEEEHHHHHHCCC
60.5223806337
219SuccinylationPITLYLEKEREKEIS
CEEEEEHHHHHHCCC
60.52-
219SuccinylationPITLYLEKEREKEIS
CEEEEEHHHHHHCCC
60.5223806337
219UbiquitinationPITLYLEKEREKEIS
CEEEEEHHHHHHCCC
60.52-
226PhosphorylationKEREKEISDDEAEEE
HHHHHCCCHHHHHHH
39.8527087446
237UbiquitinationAEEEKGEKEEEDKED
HHHHHCCCCCCCCCC
78.1922790023
255PhosphorylationPKIEDVGSDEEDDSG
CCCCCCCCCCCCCCC
41.5227087446
261PhosphorylationGSDEEDDSGKDKKKK
CCCCCCCCCCCCHHH
61.1324925903
273AcetylationKKKTKKIKEKYIDQE
HHHHHHHHHHHCCHH
57.9722826441
273MalonylationKKKTKKIKEKYIDQE
HHHHHHHHHHHCCHH
57.9726320211
275AcetylationKTKKIKEKYIDQEEL
HHHHHHHHHCCHHHH
42.3722826441
275MalonylationKTKKIKEKYIDQEEL
HHHHHHHHHCCHHHH
42.3726320211
275UbiquitinationKTKKIKEKYIDQEEL
HHHHHHHHHCCHHHH
42.3722790023
276PhosphorylationTKKIKEKYIDQEELN
HHHHHHHHCCHHHHH
15.7225159016
284AcetylationIDQEELNKTKPIWTR
CCHHHHHCCCCCCCC
71.2322640951
284MalonylationIDQEELNKTKPIWTR
CCHHHHHCCCCCCCC
71.2326320211
284UbiquitinationIDQEELNKTKPIWTR
CCHHHHHCCCCCCCC
71.2322790023
285PhosphorylationDQEELNKTKPIWTRN
CHHHHHCCCCCCCCC
40.7627600695
286UbiquitinationQEELNKTKPIWTRNP
HHHHHCCCCCCCCCC
35.7922790023
297PhosphorylationTRNPDDITQEEYGEF
CCCCCCCCHHHHHHH
36.60-
301PhosphorylationDDITQEEYGEFYKSL
CCCCHHHHHHHHHHH
22.62-
305PhosphorylationQEEYGEFYKSLTNDW
HHHHHHHHHHHCCCH
8.7225177544
306AcetylationEEYGEFYKSLTNDWE
HHHHHHHHHHCCCHH
44.2987981
306UbiquitinationEEYGEFYKSLTNDWE
HHHHHHHHHHCCCHH
44.2922790023
307PhosphorylationEYGEFYKSLTNDWED
HHHHHHHHHCCCHHH
29.1025521595
309PhosphorylationGEFYKSLTNDWEDHL
HHHHHHHCCCHHHCE
37.9226745281
347AcetylationPFDLFENKKKKNNIK
CCCCCCCCCCCCCCE
59.7930583291
347MalonylationPFDLFENKKKKNNIK
CCCCCCCCCCCCCCE
59.7926320211
347UbiquitinationPFDLFENKKKKNNIK
CCCCCCCCCCCCCCE
59.79-
348UbiquitinationFDLFENKKKKNNIKL
CCCCCCCCCCCCCEE
79.25-
354AcetylationKKKKNNIKLYVRRVF
CCCCCCCEEEEEEEE
35.5723806337
354SuccinylationKKKKNNIKLYVRRVF
CCCCCCCEEEEEEEE
35.5723806337
354UbiquitinationKKKKNNIKLYVRRVF
CCCCCCCEEEEEEEE
35.57-
365PhosphorylationRRVFIMDSCDELIPE
EEEECCCCHHHHHHH
13.1923984901
366S-nitrosocysteineRVFIMDSCDELIPEY
EEECCCCHHHHHHHH
4.03-
366GlutathionylationRVFIMDSCDELIPEY
EEECCCCHHHHHHHH
4.0324333276
366S-nitrosylationRVFIMDSCDELIPEY
EEECCCCHHHHHHHH
4.0321278135
383PhosphorylationFIRGVVDSEDLPLNI
HHHCCCCCCCCCCCC
22.7726525534
391PhosphorylationEDLPLNISREMLQQS
CCCCCCCCHHHHHHH
22.5527742792
398PhosphorylationSREMLQQSKILKVIR
CHHHHHHHHHHHHHH
14.5426745281
399N6-malonyllysineREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.95-
399AcetylationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.9522640943
399MalonylationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.9526073543
399UbiquitinationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.95-
402MalonylationLQQSKILKVIRKNIV
HHHHHHHHHHHHHHH
38.8026073543
411UbiquitinationIRKNIVKKCLELFSE
HHHHHHHHHHHHHHH
32.9122790023
412GlutathionylationRKNIVKKCLELFSEL
HHHHHHHHHHHHHHH
2.7124333276
412S-palmitoylationRKNIVKKCLELFSEL
HHHHHHHHHHHHHHH
2.7126165157
417PhosphorylationKKCLELFSELAEDKE
HHHHHHHHHHHHCHH
44.3023608596
423AcetylationFSELAEDKENYKKFY
HHHHHHCHHHHHHHH
39.097976649
427AcetylationAEDKENYKKFYEAFS
HHCHHHHHHHHHHHH
48.2470053
428AcetylationEDKENYKKFYEAFSK
HCHHHHHHHHHHHHH
42.7023806337
428SuccinylationEDKENYKKFYEAFSK
HCHHHHHHHHHHHHH
42.7023806337
428UbiquitinationEDKENYKKFYEAFSK
HCHHHHHHHHHHHHH
42.70-
434O-linked_GlycosylationKKFYEAFSKNLKLGI
HHHHHHHHHHCCCCC
27.9022645316
434PhosphorylationKKFYEAFSKNLKLGI
HHHHHHHHHHCCCCC
27.9022006019
435AcetylationKFYEAFSKNLKLGIH
HHHHHHHHHCCCCCC
60.9022826441
435MalonylationKFYEAFSKNLKLGIH
HHHHHHHHHCCCCCC
60.9026320211
435UbiquitinationKFYEAFSKNLKLGIH
HHHHHHHHHCCCCCC
60.90-
438AcetylationEAFSKNLKLGIHEDS
HHHHHHCCCCCCCCC
54.8022826441
438UbiquitinationEAFSKNLKLGIHEDS
HHHHHHCCCCCCCCC
54.8022790023
445PhosphorylationKLGIHEDSTNRRRLS
CCCCCCCCCCHHHHH
25.2925521595
446PhosphorylationLGIHEDSTNRRRLSE
CCCCCCCCCHHHHHH
45.1021082442
452O-linked_GlycosylationSTNRRRLSELLRYHT
CCCHHHHHHHHHHHH
25.1222645316
452PhosphorylationSTNRRRLSELLRYHT
CCCHHHHHHHHHHHH
25.1226824392
457PhosphorylationRLSELLRYHTSQSGD
HHHHHHHHHHCCCCC
14.9327087446
459PhosphorylationSELLRYHTSQSGDEM
HHHHHHHHCCCCCCC
21.3726239621
460PhosphorylationELLRYHTSQSGDEMT
HHHHHHHCCCCCCCC
14.7226239621
462O-linked_GlycosylationLRYHTSQSGDEMTSL
HHHHHCCCCCCCCHH
48.2322645316
462PhosphorylationLRYHTSQSGDEMTSL
HHHHHCCCCCCCCHH
48.2327087446
467PhosphorylationSQSGDEMTSLSEYVS
CCCCCCCCHHHHHHH
25.1926525534
468PhosphorylationQSGDEMTSLSEYVSR
CCCCCCCHHHHHHHH
28.7023984901
477AcetylationSEYVSRMKETQKSIY
HHHHHHHHHHHCCEE
57.4022826441
479PhosphorylationYVSRMKETQKSIYYI
HHHHHHHHHCCEEEE
35.46-
481AcetylationSRMKETQKSIYYITG
HHHHHHHCCEEEECC
46.3622826441
481SuccinylationSRMKETQKSIYYITG
HHHHHHHCCEEEECC
46.3623806337
481UbiquitinationSRMKETQKSIYYITG
HHHHHHHCCEEEECC
46.36-
482PhosphorylationRMKETQKSIYYITGE
HHHHHHCCEEEECCC
13.1525521595
484PhosphorylationKETQKSIYYITGESK
HHHHCCEEEECCCCH
8.9119605366
485PhosphorylationETQKSIYYITGESKE
HHHCCEEEECCCCHH
7.1325521595
490PhosphorylationIYYITGESKEQVANS
EEEECCCCHHHHHHH
42.7229514104
491AcetylationYYITGESKEQVANSA
EEECCCCHHHHHHHH
48.1123236377
491UbiquitinationYYITGESKEQVANSA
EEECCCCHHHHHHHH
48.1122790023
514PhosphorylationGFEVVYMTEPIDEYC
CCEEEEECCCCCHHH
22.4118779572
520PhosphorylationMTEPIDEYCVQQLKE
ECCCCCHHHHHHHHH
8.3218779572
521S-nitrosocysteineTEPIDEYCVQQLKEF
CCCCCHHHHHHHHHC
1.78-
521GlutathionylationTEPIDEYCVQQLKEF
CCCCCHHHHHHHHHC
1.7824333276
521S-nitrosylationTEPIDEYCVQQLKEF
CCCCCHHHHHHHHHC
1.7821278135
531AcetylationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.3223806337
531MethylationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.32-
531SuccinylationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.32-
531SuccinylationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.3223806337
531UbiquitinationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.32-
532PhosphorylationLKEFDGKSLVSVTKE
HHHCCCCCCEEEEHH
39.2626824392
535PhosphorylationFDGKSLVSVTKEGLE
CCCCCCEEEEHHCCC
29.3925777480
538AcetylationKSLVSVTKEGLELPE
CCCEEEEHHCCCCCC
47.8623236377
538SuccinylationKSLVSVTKEGLELPE
CCCEEEEHHCCCCCC
47.8623954790
538UbiquitinationKSLVSVTKEGLELPE
CCCEEEEHHCCCCCC
47.86-
550AcetylationLPEDEEEKKKMEESK
CCCCHHHHHHHHHHH
62.0623201123
551AcetylationPEDEEEKKKMEESKA
CCCHHHHHHHHHHHH
61.7123201123
559AcetylationKMEESKAKFENLCKL
HHHHHHHHHHHHHHH
57.8823806337
559SuccinylationKMEESKAKFENLCKL
HHHHHHHHHHHHHHH
57.8823806337
559UbiquitinationKMEESKAKFENLCKL
HHHHHHHHHHHHHHH
57.88-
564S-nitrosocysteineKAKFENLCKLMKEIL
HHHHHHHHHHHHHHH
4.85-
564S-nitrosylationKAKFENLCKLMKEIL
HHHHHHHHHHHHHHH
4.8524926564
564S-palmitoylationKAKFENLCKLMKEIL
HHHHHHHHHHHHHHH
4.8526165157
565AcetylationAKFENLCKLMKEILD
HHHHHHHHHHHHHHH
55.5722826441
565UbiquitinationAKFENLCKLMKEILD
HHHHHHHHHHHHHHH
55.5722790023
568AcetylationENLCKLMKEILDKKV
HHHHHHHHHHHHHCC
52.6322826441
568MalonylationENLCKLMKEILDKKV
HHHHHHHHHHHHHCC
52.6326320211
568SuccinylationENLCKLMKEILDKKV
HHHHHHHHHHHHHCC
52.6323806337
574MethylationMKEILDKKVEKVTIS
HHHHHHHCCEEEEEC
56.12-
574UbiquitinationMKEILDKKVEKVTIS
HHHHHHHCCEEEEEC
56.1222790023
577AcetylationILDKKVEKVTISNRL
HHHHCCEEEEECCCC
47.9023806337
577MalonylationILDKKVEKVTISNRL
HHHHCCEEEEECCCC
47.9026320211
577SuccinylationILDKKVEKVTISNRL
HHHHCCEEEEECCCC
47.90-
577SuccinylationILDKKVEKVTISNRL
HHHHCCEEEEECCCC
47.9023806337
579PhosphorylationDKKVEKVTISNRLVS
HHCCEEEEECCCCCC
29.7425521595
586PhosphorylationTISNRLVSSPCCIVT
EECCCCCCCCEEEEE
32.9026745281
587PhosphorylationISNRLVSSPCCIVTS
ECCCCCCCCEEEEEE
17.9326745281
589GlutathionylationNRLVSSPCCIVTSTY
CCCCCCCEEEEEECC
2.3924333276
590GlutathionylationRLVSSPCCIVTSTYG
CCCCCCEEEEEECCC
2.9624333276
590S-nitrosylationRLVSSPCCIVTSTYG
CCCCCCEEEEEECCC
2.96-
593PhosphorylationSSPCCIVTSTYGWTA
CCCEEEEEECCCCHH
8.7426643407
594PhosphorylationSPCCIVTSTYGWTAN
CCEEEEEECCCCHHC
14.5626643407
595PhosphorylationPCCIVTSTYGWTANM
CEEEEEECCCCHHCH
19.3825367039
596PhosphorylationCCIVTSTYGWTANME
EEEEEECCCCHHCHH
15.5020116462
607MethylationANMERIMKAQALRDN
HCHHHHHHHHHHHCC
34.67-
607UbiquitinationANMERIMKAQALRDN
HCHHHHHHHHHHHCC
34.6722790023
615PhosphorylationAQALRDNSTMGYMMA
HHHHHCCCHHHHHHH
24.8625521595
616PhosphorylationQALRDNSTMGYMMAK
HHHHCCCHHHHHHHH
22.3727600695
617SulfoxidationALRDNSTMGYMMAKK
HHHCCCHHHHHHHHH
3.4821406390
619PhosphorylationRDNSTMGYMMAKKHL
HCCCHHHHHHHHHHC
3.4825367039
620SulfoxidationDNSTMGYMMAKKHLE
CCCHHHHHHHHHHCC
1.4221406390
621SulfoxidationNSTMGYMMAKKHLEI
CCHHHHHHHHHHCCC
3.5821406390
623AcetylationTMGYMMAKKHLEINP
HHHHHHHHHHCCCCC
23.8822826441
623SuccinylationTMGYMMAKKHLEINP
HHHHHHHHHHCCCCC
23.8823954790
623UbiquitinationTMGYMMAKKHLEINP
HHHHHHHHHHCCCCC
23.88-
624AcetylationMGYMMAKKHLEINPD
HHHHHHHHHCCCCCC
43.8323806337
624UbiquitinationMGYMMAKKHLEINPD
HHHHHHHHHCCCCCC
43.8322790023
646AcetylationRQKAEADKNDKAVKD
HHHHHHCCCCHHHHH
74.2723201123
649AcetylationAEADKNDKAVKDLVV
HHHCCCCHHHHHHHH
65.5523201123
669PhosphorylationALLSSGFSLEDPQTH
HHHHCCCCCCCCCCH
34.08-
696PhosphorylationGIDEDEVTAEEPSAA
CCCCCCCCCCCCCCC
26.7225338131
701PhosphorylationEVTAEEPSAAVPDEI
CCCCCCCCCCCCCCC
31.9423649490
718PhosphorylationLEGDEDASRMEEVD-
CCCCCCHHHCCCCC-
44.4722006019

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
718SPhosphorylationKinasePLK2P53351
Uniprot
718SPhosphorylationKinasePLK3Q60806
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
226SPhosphorylation

17242355
255SPhosphorylation

15345747

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of HS90B_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
GLR_MOUSEGcgrphysical
22457490
CDN2A_MOUSECdkn2aphysical
16582619
ARF_MOUSECdkn2aphysical
16582619
IRF3_MOUSEIrf3physical
16394098
TEBP_MOUSEPtges3physical
22123826
HSF1_MOUSEHsf1physical
17785525
HDAC6_MOUSEHdac6physical
17785525
TERA_MOUSEVcpphysical
17785525
ITBP2_MOUSEItgb1bp2physical
18474241
HDAC6_MOUSEHdac6physical
22367781
HS90B_MOUSEHsp90ab1physical
22367781
HSF1_MOUSEHsf1physical
22367781

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of HS90B_MOUSE

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry.";
Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
Mol. Cell. Proteomics 8:904-912(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"The phagosomal proteome in interferon-gamma-activated macrophages.";
Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.;
Immunity 30:143-154(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry.";
Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.;
J. Proteome Res. 7:5314-5326(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-255, ANDMASS SPECTROMETRY.
"Large-scale phosphorylation analysis of mouse liver.";
Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Mitochondrial phosphoproteome revealed by an improved IMAC method andMS/MS/MS.";
Lee J., Xu Y., Chen Y., Sprung R., Kim S.C., Xie S., Zhao Y.;
Mol. Cell. Proteomics 6:669-676(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations.";
Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.;
Mol. Cell. Proteomics 6:283-293(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry.";
Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.;
J. Proteome Res. 6:250-262(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-255, ANDMASS SPECTROMETRY.
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis.";
Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
J. Proteome Res. 7:3957-3967(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-255, ANDMASS SPECTROMETRY.
"A differential phosphoproteomic analysis of retinoic acid-treated P19cells.";
Smith J.C., Duchesne M.A., Tozzi P., Ethier M., Figeys D.;
J. Proteome Res. 6:3174-3186(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255 AND SER-261, ANDMASS SPECTROMETRY.
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain.";
Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.;
J. Proteome Res. 7:311-318(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-305, AND MASSSPECTROMETRY.
"Quantitative time-resolved phosphoproteomic analysis of mast cellsignaling.";
Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., Kawakami Y.,Kawakami T., Salomon A.R.;
J. Immunol. 179:5864-5876(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-484, AND MASSSPECTROMETRY.

TOP